Novo Holdings has received the green light for its giant acquisition of the American pharmaceutical manufacturer Catalent, Ritzau reports.According to a stock exchange announcement, all regulatory conditions for the completion of the acquisition have now been met, which includes approval in the EU, by competition authorities and in the USA.“The parties are now free to […]